Page last updated: 2024-12-10
broparoestrol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
broparoestrol: non-steroid compound with estrogenic activity; RN given refers to cpd without isomeric designation; synonym LN 2299 refers to (cis)-isomer; LN 1643 refers to (trans)-isomer; structure in Merck Index, 9th ed, #1451 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 3032769 |
| SCHEMBL ID | 146181 |
| MeSH ID | M0045591 |
Synonyms (39)
| Synonym |
|---|
| ln 1643 |
| ethylene, 1-bromo-1,2-diphenyl-2-(p-ethylphenyl)-, (e)- |
| benzene, 1-(2-bromo-1,2-diphenylethenyl)-4-ethyl-, (e)- |
| bromo-1 (p-ethylphenyl)-2 diphenyl-1,2 ethylene (e) [french] |
| trans-broparestrol |
| (e)-1-bromo-1,2-diphenyl-2-(p-ethylphenyl)ethylene |
| (e)-1-(2-bromo-1,2-diphenylethenyl)-4-ethylbenzene |
| broparoestrol |
| 1-[(e)-2-bromo-1,2-diphenylethenyl]-4-ethylbenzene |
| unii-7u06d381uq |
| longestrol |
| broparestrol [inn:dcf] |
| l.n. 107 |
| broparestrol |
| 7u06d381uq , |
| 1-bromo-2-p-(ethylphenyl)-1,2-diphenylethylene |
| 479-68-5 |
| ln 107 |
| (e,z)-1-brom-2-(4-ethylphenyl)-1,2-diphenylethylen |
| einecs 207-537-1 |
| broparestrolum |
| broparoestrolum |
| 2-brom-1-(4-ethylphenyl)-1,2-diphenylethylen |
| broparestrolum [inn-latin] |
| broparestrol (e)- |
| unii-4f4uxv47yi |
| 22393-62-0 |
| 4f4uxv47yi , |
| bromo-1 (p-ethylphenyl)-2 diphenyl-1,2 ethylene (e) |
| SCHEMBL146181 |
| ln-1643 |
| (e)-broparestrol |
| 1-(2-bromo-1,2-diphenylethenyl)-4-ethylbenzene, (e)- |
| ethylene, 1-bromo-2-(p-ethylphenyl)-1,2-diphenyl-, (e)- |
| broparestrol (e)-form [mi] |
| Q25091458 |
| DTXSID201203500 |
| (e)-(1-bromo-2-(4-ethylphenyl)ethene-1,2-diyl)dibenzene |
| AKOS040759886 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||